InvestorsObserver is giving Immunovant Inc (IMVT) an Analyst Rating Rank of 60, meaning IMVT is ranked higher by analysts than 60% of stocks. The average price target for IMVT is $27.875 and analyst’s rate the stock as a Strong Buy.
Wall Street analysts are rating IMVT a Strong Buy today. Find out what this means to you and get the rest of the rankings on IMVT!